Institute

Max Planck Institute of Colloids and Interfaces

Max­Planck­Research Magazine

Issue 2018

MaxPlanckResearch 3/2018

How cells get their shape

Some time around four billion years ago, life started to become encapsulated. The first cells emerged – protected spaces that facilitated the bonding of complex molecules. Petra Schwille from the Max Planck Institute of Biochemistry in Martinsried and Rumiana Dimova from the Max Planck Institute of Colloids and Interfaces in Potsdam are exploring the boundaries of cellular life. The two researchers are investigating the dynamics of biomembranes.
Issue 2015

MaxPlanckResearch - 4/2015

A Scientist with a Sweet Tooth
Basic scientist, entrepreneur, citizen and family man: what Peter Seeberger, Director at the Max Planck Institute of Colloids and Interfaces in Potsdam, manages to cram into one lifetime would take others three. One of his goals is to prevent diseases that afflict particularly people in developing countries – and his weapon of choice is sugar.
Issue 2014

1/2014

A Prescription for New Drugs
During the 20th century, the pharmaceutical industry made crucial strides in advancing drug development. In recent times, however, the sector has seen noticeable cost-related cutbacks in research activity. We urgently need new drugs for the treatment of cancer, dementia and many other diseases. In developing countries, the problem is a matter of life and death. Our author pleads for a radical rethinking of the drug development system, and for the involvement of basic research.
Issue 2013

MaxPlanckResearch 3/2013

More than Just Sweet
When they hear the word sugar, the first thing most people think of is candy. Some may also think of diabetes. Peter H. Seeberger from the Max Planck Institute of Colloids and Interfaces in Golm, in contrast, wants to use sugars to develop more effective drugs and vaccines. He hopes his work will benefit primarily poorer countries.

MaxPlanckResearch 1/2013

Bone Scaffold Covers All Angles
Patients with osteoporosis stand to gain just as much from artificial bone as those with serious injuries and bone cancer. Peter Fratzl, John Dunlop and Wolfgang Wagermaier are researching the optimum conditions for generating bone tissue at the Max Planck Institute of Colloids and Interfaces in Potsdam-Golm.
Issue 2012

MaxPlanckResearch 4/2012

Building Blocks for Nanotransporters

Active ingredients for chemotherapy, corrosion protection products or vitamins: packaging substances in tiny containers, transporting them to their intended destination – if need be, even in the human body – and unloading them there would be of interest for many applications. Helmuth Möhwald and his colleagues at the Max Planck Institute of Colloids and Interfaces are developing the methods that will make all this possible.
Issue 2010

MPR 3 /2010

Magnets – Made by Microbes
Magnetic nanoparticles such as those produced by magnetotactic bacteria could help detect tumors, and would be of great value in medicine.
Issue 2009

MPR 3 /2009

The Miracle of Space in the Tank
Researchers are testing new storage solutions for hydrogen cars.
Issue 2007
Go to Editor View